Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jiqing Li et al, published in Journal of Thrombosis and Haemostasis, adding:
“The dual role of P2RY12: Impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy.
In 1828 STEMI patients on ticagrelor, P2RY12 polymorphisms and expression levels showed opposing effects on ischemic and bleeding risks, revealing novel nonlinear relationships for refined cardiovascular risk stratification.”
Title: The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy
Authors: Jiqing Li, Zheng Gong, Shikun Wang, Jianhua Gu, Shuo Wu, Jiaojiao Pang, Yuguo Chen
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 20, 2026, 13:18Ekaterina Balaian: Submission Open for Special Issue on Hematologic Metabolism
-
Jul 20, 2026, 12:54Victor Emmanuel: Preventing Severe Maternal Complications Associated With Anemia
-
Jul 20, 2026, 12:33Ney Carter Borges: The Evolving Role of Aspirin in Coronary Artery Disease
-
Jul 20, 2026, 12:15Zain Khalpey: Why the Cause of Reduced Perfusion Matters
-
Jul 20, 2026, 11:53ISTH 2026 Showcases Landmark Research and Launches Women’s Health Hub
-
Jul 20, 2026, 10:40Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
-
Jul 20, 2026, 10:30Marc Blondon: What Are the Current Practices For VTE Prevention in Pregnancy Worldwide?
-
Jul 20, 2026, 10:11Zeyad Bady: Advancing Thrombosis Research on the International Stage at ISTH 2026
-
Jul 20, 2026, 09:41Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026